Kolexia
Golmard Lisa Pharmacien
Golmard Lisa
Pharmacien
Clcc Institut Curie
Paris, France
125 Activités
80 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Prédisposition génétique à une maladie Tumeurs de l'ovaire Tumeurs du sein Rétinoblastome Carcinomes Tumeurs de l'estomac Syndrome d'Ehlers-Danlos Tumeurs de la rétine Mélanome

Collaborateurs

Voir plus
Stoppa-Lyonnet Dominique
Stoppa-Lyonnet Dominique
Clcc Institut Curie, Paris, France
Colas Chrystelle
Colas Chrystelle
Clcc Institut Curie, Paris, France
Houdayer Claude
Houdayer Claude
Hôpital Charles Nicolle, Rouen, France
Gauthier-Villars Marion
Gauthier-Villars Marion
Clcc Institut Curie, Paris, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Adaptive Nanopore Sequencing as a preeminent tool to elucidate structural variants in cancer predisposition genes
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Genotype-phenotype correlations in retinoblastoma
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
CTNNA1 germline variants with a premature termination codon are a risk factor for development of early-onset Diffuse Gastric Cancer
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Adaptive Nanopore sequencing to determine pathogenicity of BRCA1 exonic duplication
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
Breast (Edinburgh, Scotland)   10 décembre 2023
Familial uveal melanoma and other tumours in 25 families with monoallelic germline MBD4 variants.
Journal of the National Cancer Institute   07 décembre 2023
Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction.
Breast (Edinburgh, Scotland)   29 novembre 2023
PROGNOSTIC VALUE OF MOLECULAR MARKERS IN UNILATERAL RETINOBLASTOMA TREATED BY FIRST-LINE ENUCLEATION
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
Mosaic promoter methylation contribution in hereditary breast/ovarian cancer pedigrees.
Journal of medical genetics   25 septembre 2023